|
Microzide Effects of aging and antihypertensive treatment on aortic internal diameter in spontaneously hypertensive rats.
Giummelly P, Lartaud-Idjouadiene I, Marque V, Niederhoffer N, Chillon JM, Capdeville-Atkinson C, Atkinson J.
Laboratoire de Pharmacologie Cardiovasculaire, Faculte de Pharmacie, Henri Poincare University-Nancy 1, Nancy, France.
The effect of antihypertensive treatment on the development of large-artery remodeling in young animals has been widely studied, but reversal of established changes in older hypertensive animals has been largely ignored, although the latter represents a better paradigm for the human condition. We studied the effect of treatment with captopril plus hydrochlorothiazide, from 3 months onward, on geometry and wall stress of the thoracic aorta of adult (9 months, maturation) and old (15 months, senescence) spontaneously hypertensive rats; normotensive Wistar-Kyoto rats were used as controls. At 3 months of age, blood pressure, medial cross-sectional area, and internal diameter were higher in spontaneously hypertensive rats than in Wistar-Kyoto rats. In both strains, medial cross-sectional area and lumen diameter increased during maturation; there was little change with senescence. Changes in blood pressure were minor. Because medial hypertrophy failed to compensate for the wider lumen and higher intraluminal pressure in spontaneously hypertensive rats, medial stress was higher in these rats than in Wistar-Kyoto rats. Captopril plus hydrochlorothiazide rapidly lowered blood pressure and medial cross-sectional area. Despite a marked fall in blood pressure, the internal diameter of the thoracic aorta of treated animals was similar to that of untreated animals after 6 months of treatment and started to fall only after the animals had been treated for 1 year. Thus, under treatment with captopril plus hydrochlorothiazide, medial stress remained elevated, even after very-long-term treatment, because medial cross-sectional area was not adapted to internal diameter. We suggest that some changes in large-artery structure associated with hypertension and aging, such as the increase in diameter, take considerable time to regress after blood pressure is lowered, and this may explain why, despite treatment, wall stress remains elevated.
Online source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10454442&dopt=Abstract hydrochlorothiazide Microzide
Microzide Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats.
Brosnan MJ, Hamilton CA, Graham D, Lygate CA, Jardine E, Dominiczak AF.
BHF Blood Pressure Group, University of Glasgow, Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK. mjb8n clinmed.gla.ac.uk
OBJECTIVE : To determine the effects of the angiotensin II receptor antagonist irbesartan, the calcium-channel blocker amlodipine, and hydrochlorothiazide/hydralazine on superoxide, NAD(P)H oxidase and nitric oxide bioavailability in spontaneously hypertensive stroke-prone rats (SHRSP). METHODS : Drugs or vehicle were administered for 8 weeks to SHRSP and blood pressure was measured weekly by tail-cuff plethysmography. After 8 weeks, superoxide levels in carotid arteries and aortas were measured by lucigenin chemiluminescence and p22phox expression quantified by immunohistochemistry. In vitro the effects of exposure to drugs and vehicle for 30 min and 4 h on superoxide levels and nitric oxide bioavailability were examined. The latter was expressed as the increase in contractile responses of carotid arteries to phenylephrine in the presence of the nitric oxide synthase inhibitor NG-nitro-l-arginine methyl ester(l-NAME). RESULTS : In vivo irbesartan, amlodipine and hydrochlorothiazide/hydralazine produced similar falls in blood pressure, from 162 +/- 4 to 125 +/- 5, 132 +/- 4 and 131 +/- 6 mmHg, respectively, but irbesartan caused a greater reduction in superoxide and p22phox; superoxide levels in carotid arteries being 3.1 +/- 0.3, 1.1 +/- 0.2, 1.9 +/- 0.3 and 2.0 +/- 0.3 nmoles/mg per min, respectively. In vitro 4 h exposure to irbesartan decreased superoxide levels in the aorta from 2.08 +/- 0.68 to 1.48 +/- 0.62 nmoles/mg per min and increased nitric oxide bioavailability in carotid arteries. Neither 30 min incubation with irbesartan nor 4 h with amlodipine or hydrochlorothiazide/hydralazine altered superoxide levels. CONCLUSIONS : These studies support the hypothesis that AT1 receptor blockade has beneficial effects on superoxide production and nitric oxide bioavailability above that of other classes of antihypertensive agents. Reduced expression of components of the NAD(P)H oxidase may contribute to these effects.
Online source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11821713&dopt=Abstract hydrochlorothiazide Microzide
Microzide Simultaneous determination of benazepril hydrochloride and hydrochlorothiazide by micro-bore liquid chromatography.
Panderi IE, Parissi-Poulou M.
Department of Pharmacy, University of Athens, Panepistimiopolis Zografou, Greece.
A micro-bore liquid chromatographic method was developed for the simultaneous determination of benazepril hydrochloride and hydrochlorothiazide in pharmaceutical dosage forms. The use of a BDS C-18 micro-bore analytical column, results in substantial reduction in solvent consumption and increased sensitivity. The mobile phase consisted of a mixture of 0.025 M sodium dihydrogen phosphate (pH 4.8) and acetonitrile (55:45, v/v), pumped at a flow rate of 0.40 ml min(-1). Detection was set at 250 nm using an ultraviolet detector. Calibration graphs are linear (r better than 0.9991, n = 5), in concentration range 5.0-20.0 microg ml(-1) for benazepril hydrochloride and 6.2-25.0 microg ml(-1) for hydrochlorothiazide. The intra- and interday R.S.D. values were <1.25% (n = 5), while the relative percentage error (Er) was <0.9% (n = 5). The detection limits attained according to IUPAC definition were 0.88 and 0.58 microg ml(-1) for benazepril hydrochloride and hydrochlorothiazide, respectively. The method was applied in the quality control of commercial tablets and content uniformity test and proved to be suitable for rapid and reliable quality control.
Online source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10703970&dopt=Abstract hydrochlorothiazide Microzide
Microzide Simultaneous determination of benazepril hydrochloride and hydrochlorothiazide in tablets by second-order derivative spectrophotometry.
Panderi IE.
Department of Pharmacy, University of Athens, Zografou, Greece.
A second-order derivative spectrophotometric method for the simultaneous determination of benazepril hydrochloride and hydrochlorothiazide in pharmaceutical dosage forms is described. The determination of benazepril hydrochloride in the presence of hydrochlorothiazide was achieved by measuring the second-order derivative signals at 253.6 and 282.6 nm, while the second-order derivative signal at 282.6 nm was measured for the determination of hydrochlorothiazide. The linear dynamic ranges were 14.80-33.80 microg ml(-1) for benazepril hydrochloride and 18.50-42.20 microg ml(-1) for hydrochlorothiazide, the correlation coefficient for the calibration graphs were better than 0.9998, n = 5, the precision (%RSD) was better than 1.43% and the accuracy was satisfactory (Er < 0.99%). The detection limits were found to be 2.46 and 1.57 microg ml(-1) for benazepril hydrochloride and hydrochlorothiazide, respectively. The method was applied in the quality control of commercial tablets and proved to be suitable for rapid and reliable quality control.
Online source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10703980&dopt=Abstract hydrochlorothiazide Microzide
Microzide Determination of active ingredients in the pharmaceutical formulations containing hydrochlorothiazide and its binary mixtures with benazepril hydrochloride, triamterene and cilazapril by ratio spectra derivative spectrophotometry and vierordt's method.
Erk N.
Department of Analytical Chemistry, Faculty of Pharmacy, University of Ankara, Turkey.
Procedures were developed for the simultaneous determination of pharmaceuticals in binary mixtures, containing hydrochlorothiazide-benazepril hydrochloride, hydrochlorothiazide triamterene and hydrochlorothiazide cilazapril by ratio spectra derivative spectrophotometry and Vierordt's method. Mean recoveries, relative standard deviations and linearity ranges in calibration graphs of the methods were compared. These procedures were successfully applied to three pharmaceutical formulations for the determination of active ingredients.
Online source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10704019&dopt=Abstract hydrochlorothiazide Microzide
Microzide (hydrochlorothiazide) References
Microzide or hydrochlorothiazide 1 |
Microzide or hydrochlorothiazide 2 |
Microzide or hydrochlorothiazide 3 |
Microzide or hydrochlorothiazide 4 |
Microzide or hydrochlorothiazide 5 |
Microzide or hydrochlorothiazide 6 |
Microzide or hydrochlorothiazide 7 |
Microzide or hydrochlorothiazide 8 |
Microzide or hydrochlorothiazide 9 |
Microzide or hydrochlorothiazide 10 |
Microzide or hydrochlorothiazide 11 |
Microzide or hydrochlorothiazide 12 |
Microzide or hydrochlorothiazide 13 |
Microzide or hydrochlorothiazide 14 |
Microzide or hydrochlorothiazide 15 |
Microzide or hydrochlorothiazide 16 |
Microzide or hydrochlorothiazide 17 |
Microzide or hydrochlorothiazide 18 |
Microzide or hydrochlorothiazide 19 |
Microzide or hydrochlorothiazide 20 |
Microzide or hydrochlorothiazide 21 |
Microzide or hydrochlorothiazide 22 |
Microzide or hydrochlorothiazide 23 |
Microzide or hydrochlorothiazide 24 |
Microzide or hydrochlorothiazide 25 |
Microzide or hydrochlorothiazide 26 |
Microzide or hydrochlorothiazide 27 |
Microzide or hydrochlorothiazide 28 |
Microzide or hydrochlorothiazide 29 |
Microzide or hydrochlorothiazide 30 |
Microzide or hydrochlorothiazide 31 |
Microzide or hydrochlorothiazide 32 |
Microzide or hydrochlorothiazide 33 |
Microzide or hydrochlorothiazide 34 |
Microzide or hydrochlorothiazide 35 |
Microzide or hydrochlorothiazide 36 |
Microzide or hydrochlorothiazide 37 |
Microzide or hydrochlorothiazide 38 |
Microzide or hydrochlorothiazide 39 |
Microzide or hydrochlorothiazide 40 |
Microzide or hydrochlorothiazide 41 |
Microzide or hydrochlorothiazide 42 |
Microzide or hydrochlorothiazide 43 |
Microzide or hydrochlorothiazide 44 |
Microzide or hydrochlorothiazide 45 |
Microzide or hydrochlorothiazide 46 |
Microzide or hydrochlorothiazide 47 |
Microzide or hydrochlorothiazide 48 |
Microzide or hydrochlorothiazide 49 |
Microzide or hydrochlorothiazide 50 |
Microzide or hydrochlorothiazide 51 |
Microzide or hydrochlorothiazide 52 |
Microzide or hydrochlorothiazide 53 |
Microzide or hydrochlorothiazide 54 |
Microzide or hydrochlorothiazide 55 |
Microzide or hydrochlorothiazide 56 |
Microzide or hydrochlorothiazide 57 |
Microzide or hydrochlorothiazide 58
| |